Few developments have received as much attention or palpable enthusiasm in the reproductive
field in recent decades as long-acting reversible contraception (LARC). Though the
term may be changing, here LARC refers to intrauterine contraception (IUC), implants
and other in-development methods that prevent pregnancy for extended time periods
without user action. Reproductive health journals and conferences increasingly — and
even overwhelmingly — feature articles, panels and clinical trainings on LARC, and
for good reason. Rates of unintended pregnancy have actually increased among the most socially disadvantaged women in recent years [
[1]
], suggesting an inadequacy of current prevention approaches.To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to ContraceptionAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Disparities in rates of unintended pregnancy in the United States, 1994 and 2001.Perspect Sex Reprod Health. 2006; 38: 90-96
- Contraceptive failure in the United States.Contraception. 2011; 83: 397-404
- The Contraceptive CHOICE Project: reducing barriers to long-acting reversible contraception.Am J Obstet Gynecol. 2010; 203: 115.e1-115.e7
- The potential of long-acting reversible contraception to decrease unintended pregnancy.Contraception. 2008; 78: 197-200
- Meeting the contraceptive needs of teens and young adults: youth-friendly and long-acting reversible contraceptive services in U.S. family planning facilities.J Adolesc Health. 2013; 52: 284-292
- Long-acting removable contraceptives prevent teen pregnancy.J Adolesc Health. 2013; 52: 255-256
- Burden of unintended pregnancy in the United States: potential savings with increased use of long-acting reversible contraception.Contraception. 2013; 87: 154-161
- Long-acting reversible contraception for adolescents and young adults: patient and provider perspectives.J Pediatr Adolesc Gynecol. 2013; 26: 86-95
- Contraceptive technology. 20th rev. ed. Ardent Media, New York, NY2011
- Twenty-four-month continuation of reversible contraception.Obstet Gynecol. 2013; 122: 1083-1091
- Relative cost effectiveness of Depo-Provera, Implanon, and Mirena in reversible long-term hormonal contraception in the UK.Pharmacoeconomics. 2004; 22: 1141-1151
- The pleasure deficit: revisiting the “sexuality connection” in reproductive health.Perspect Sex Reprod Health. 2007; 39: 240-247
- Evaluation of quality of life and sexual functioning of women using levonorgestrel-releasing intrauterine contraceptive system—Mirena.Coll Antropol. 2008; 32: 1059-1068
- Use of the Levonorgestrel-IUS in the treatment of menorrhagia: assessment of quality of life in Turkish users.Arch Gynecol Obstet. 2009; 279: 835-840
- User satisfaction with a levonorgestrel-releasing intrauterine system (LNG-IUS): data from an international survey.Eur J Contracept Reprod Health Care. 2009; 14: 391-398
- Use of the Mirena LNG-IUS and Paragard CuT380A intrauterine devices in nulliparous women.Contraception. 2010; 81: 367-371
- Copper intrauterine device use by nulliparous women: review of side effects.Contraception. 2007; 75: S8-S11
- Promises I can keep: why poor women put motherhood before marriage. University of California Press, Berkeley2005
- Pleasure and power: incorporating sexuality and inequality into research on contraceptive use and unintended pregnancy.Am J Public Health. 2008; 98: 1803-1813
- Pleasure, prophylaxis and procreation: a qualitative analysis of intermittent contraceptive use and unintended pregnancy.Perspect Sex Reprod Health. 2008; 40: 130-137
- Directive counseling on long-acting contraception.Am J Public Health. 1996; 86: 787-790
- Beyond birth control: the overlooked benefits of oral contraceptive pills. The Guttmacher Institute, New York2011
- Killing the black body: race, reproduction, and the meaning of liberty. 1st. pbk. ed. Vintage, New York1999
- Undivided rights: women of color organize for reproductive justice. South End Press, Cambridge, MA2004
- Woman's body, woman's right: a social history of birth control in America. Grossman, New York1976
- Women, race, & class. 1st ed. Random House, New York1981
- Population policy & women's rights: transforming reproductive choice. Praeger, Westport, CT1993
- Fatal misconception: the struggle to control world population. Belknap Press of Harvard University Press, Cambridge, MA2008
- Current contraceptive use in the United States, 2006–2010, and changes in patterns of use since 1995. National Council for Health Statistics, Hyattsville, MD2012 (Contract No.: no. 60.)
- From Norplant to the contraceptive vaccine: new frontiers of population control.in: Ratcliff K.S. Women and health: power, technology, and conflict in a gendered world. Allyn and Bacon, Boston2002: 197-204
- Changes in use of long-acting contraceptive methods in the United States, 2007–2009.Fertil Steril. 2012; 98: 893-897
- Racial differences in Norplant use in the United States.Soc Sci Med. 2000; 50: 1297-1308
- Recommendations for intrauterine contraception: a randomized trial of the effects of patients' race/ethnicity and socioeconomic status.Am J Obstet Gynecol. 2010; 203: 319.e1-319.e8
- Choice & coercion: birth control, sterilization, and abortion in public health and welfare. University of North Carolina Press, Chapel Hill2005
- A new vision for advancing our movement for reproductive health, reproductive rights, and reproductive justice. Asian Communities for Reproductive Justice, SisterSong Women of Color Reproductive Health Collective, Oakland, CA2005
Article info
Publication history
Published online: February 12, 2014
Accepted:
January 31,
2014
Received:
January 22,
2014
Footnotes
☆Disclaimer: The views expressed in this editorial are solely those of the authors and do not necessarily reflect the opinions or views of the Association of Reproductive Health Professionals or its representatives.
☆☆No conflicts of interest need to be noted.
Identification
Copyright
© 2014 Elsevier Inc. Published by Elsevier Inc. All rights reserved.
